Autek China Inc.

300595

CNE100002MR0

Medical Equipment, Supplies & Distribution

End-of-day quote Shenzhen S.E. Other stock markets 23:00:00 21/05/2024 BST			5-day change	1st Jan Change
18.93 ^CNY	-0.47%		-0.68%	-16.16%

05-10	Autek China Inc. Announces Cash Dividend of A Shares for the Year 2023, Payable on May 16, 2024	CI
04-29	Nomura Adjusts Autek China’s Price Target to 19.96 Yuan From 22.16 Yuan, Keeps at Neutral	MT

Autek China Inc. Announces the Profit Distribution Proposal for 2022

April 02, 2023

Autek China Inc. announced on 03 April 2023 the profit distribution proposal of cash dividend (tax included) of CNY 1.40000000 per 10 shares for 2022.

Latest news about Autek China Inc.

Autek China Inc. Announces Cash Dividend of A Shares for the Year 2023, Payable on May 16, 2024	05-10	CI
Nomura Adjusts Autek China’s Price Target to 19.96 Yuan From 22.16 Yuan, Keeps at Neutral	04-29	MT
Autek China Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	04-26	CI
Autek China Inc. Announces Profit Distribution Proposal for 2023	04-01	CI
Nomura Adjusts Ovctek China’s Price Target to 22.16 Yuan From 25.69 Yuan, Keeps at Neutral	03-13	MT
Autek China Inc. Reports Earnings Results for the Nine Months Ended September 30, 2023	23/10/23	CI
Nomura Adjusts Ovctek China's Price Target to 30.19 Yuan From 33.83 Yuan, Keeps at Neutral	14/08/23	MT
Autek China Logs Double-Digit Earnings Growth in H1	11/08/23	MT
Autek China Inc. Reports Earnings Results for the Half Year Ended June 30, 2023	10/08/23	CI
Autek China Elects Founder as Chairman, General Manager	19/06/23	MT
Autek China Inc. signed the share transfer agreement to acquire a 39% stake in Shenzhen Mingmou Ruishi Eye Clinic from Zhao Xiaoting, and Li Xianting for CNY 20.7 million.	18/06/23	CI
Autek China Inc. signed the share transfer agreement to acquire a 39% stake in Kunming Shikang Eye Clinic Co., Ltd. from Yunnan Shilikang Enterprise Management Partnership Enterprise (Limited Partnership), Zhang Mingjing, and Ouyang Zhonghua for CNY 58.2 million.	18/06/23	CI
Autek China Inc. agreed to acquire an additional 30% stake in Xuancheng Autek Baixiu Medical Devices Co., Ltd. from Huang Guanglu and Liu Jihua for CNY 21.93 million	18/06/23	CI
Autek China Inc. agreed to acquire an additional 38.99% stake in Xuancheng Mengdaiwei Medical Devices Co., Ltd. from Huangyan Yulu and Hu Chenying for CNY 21.15 million	18/06/23	CI
Autek China Inc. entered into an agreement to acquire additional 39% stake in Quanzhou Autek Optical Technology Co., Ltd. from Zhuang Chaoyang, and Zheng Jing for approximately CNY 30 million.	18/06/23	CI
Autek Investment Co., Ltd. entered into an agreement to acquire 39% stake in Suzhou Kangshi Health Eye Information Consulting Co., Ltd. from Yuan Lili and Sun Weiling for CNY 107 million.	18/06/23	CI
Autek China Inc. agreed to acquire a 39% stake in Xiantao Jiashi Eye Clinic Co., Ltd. from Wang Tiehan for CNY 17.41 million	18/06/23	CI
Autek China Inc. signed the share transfer agreement to acquire an additional 39% stake in Bengbu Autek Optical Equipment Technology Co., Ltd. from Shi Jing for CNY 45 million.	18/06/23	CI
Autek China Inc. signed the share transfer agreement to acquire a 39% stake in Xuancheng Dental Hospital Co., Ltd. from Huang Chaohui, He Xiaoqing for CNY 16.3 million.	18/06/23	CI
Autek China Inc. (SZSE : 300595) signed the share transfer agreement to acquire additional 39% stake in Fuzhou Autek Medical Devices Co., Ltd. from Ye Xiaodan, Liao Lianming and Luo Dongming for CNY 20.4 million.	18/06/23	CI
Autek China Inc. (SZSE : 300595) signed the share transfer agreement to acquire additional 39% stake in Fuzhou Autek Medical Devices Co., Ltd. from Ye Xiaodan, Liao Lianming and Luo Dongming for approximately CNY 120 million.	18/06/23	CI
Autek China Inc. (SZSE : 300595) signed the share transfer agreement to acquire additional 39% stake in Jingjiang Autek Jingcheng Eye Health Service Co., Ltd. from Hou Aihua and Lu Hanxing for CNY 21.5 million.	18/06/23	CI
Autek China Inc. Announces Final Dividend on A Shares for the Year 2022, Payable on May 16, 2023	09/05/23	CI
Autek China Inc. Approves Election of Xu Qiang Independent Director	27/04/23	CI
Autek China Inc. Approves 2022 Profit Distribution Plan	27/04/23	CI

Autek China Inc is a China-based company principally engaged in the research and development, production and sales of eye-sight products and the provision of eye-sight services. The Company's main business is non-surgical vision correction. The Company's main products include orthokeratology, general contact lens and care products. Its core product is Dream David orthokeratology. In addition, The Company is also engaged in general glass frame sales business. The Company mainly operates its business in the domestic market.

Sector

Medical Equipment, Supplies & Distribution

Calendar

28/08/2024 - Q2 2024 Earnings Release (Projected)

More about the company

Income Statement Evolution

More financial data

Ratings for Autek China Inc.

Trading Rating

Investor Rating

ESG Refinitiv

D+

More Ratings

Analysts' Consensus

Sell

Buy

Mean consensus

BUY

Number of Analysts

Last Close Price

18.93 CNY

Average target price

24.85 CNY

Spread / Average Target

+31.29%

Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Glasses, Spectacles & Contact Lenses

	1st Jan change	Capi.
AUTEK CHINA INC.	-16.16%	2.36B
ESSILORLUXOTTICA	+14.76%	103B
ALCON INC.	+25.59%	43.67B
THE COOPER COMPANIES, INC.	+2.43%	19.23B
PEGAVISION CORPORATION	+26.36%	1.23B
MINGYUE OPTICAL LENS CO.,LTD.	-35.50%	755M
UNIVERSAL VISION BIOTECHNOLOGY CO., LTD.	-7.04%	683M
MENICON CO., LTD.	-45.13%	666M
VIZIONFOCUS INC.	+22.83%	501M
SHANGHAI CONANT OPTICAL CO., LTD.	+27.20%	479M

Glasses, Spectacles & Contact Lenses

Autek China Inc.

Equities

300595

CNE100002MR0

Medical Equipment, Supplies & Distribution

Autek China Inc. Announces the Profit Distribution Proposal for 2022

Latest news about Autek China Inc.

Chart Autek China Inc.

Company Profile

Income Statement Evolution

Ratings for Autek China Inc.

Analysts' Consensus

EPS Revisions

Quarterly earnings - Rate of surprise

Sector Glasses, Spectacles & Contact Lenses